Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-17
1997-01-14
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5462684, 5462747, 5462751, 546118, A61K 3144, C07D40114
Patent
active
055940102
ABSTRACT:
The substituted monopyridyl and bipyridyl derivatives are prepared by reacting substituted pyridine halides with phenylboronic acids. They are suitable for use as active compounds in medicaments for treating arterial hypertension and atherosclerosis.
REFERENCES:
patent: 5128327 (1992-07-01), Chakravarty et al.
patent: 5283242 (1994-02-01), Ellingboe
patent: 5328911 (1994-07-01), Miyake et al.
patent: 5389634 (1995-02-01), Fortin et al.
The Journal of Cell Biology, vol. 50, 1971, pp. 172-186; "The Smooth Muscle Cell", R. Ross.
Biorganic & Medical Chemistry Letters, vol. 3, No. 6, 1993, pp. 1055-1060.
J. Med. Chem. vol. 36, Martin Winn et al., pp. 2676-2688, 1993.
Beuck Martin
Bischoff Hilmar
Denzer Dirk
Dressel J urgen
Fey Peter
Bayer Aktiengesellschaft
Dentz Bernard
LandOfFree
Substituted monopyridylmethyl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted monopyridylmethyl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted monopyridylmethyl derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1388512